Brian Edwin Cathers, Chief Scientific Officer

GBT 273 shares

The estimated Net Worth of Brian Edwin Cathers is at least $11,239.41. Brian Edwin Cathers owns over 273 units of Global Blood Therapeutics, Inc. stock worth over $11,239.41.

Transaction DateCompanySharesTypeOwnedPriceValuePost Value
31st January 2020GBT - Global Blood Therapeutics, Inc.273Grant/award etc.273$41.17$11,239.41$11,239.41
1st March 2020GBT - Global Blood Therapeutics, Inc.2,594Payment by withholding5,179$63.96$165,912.24$331,248.84
1st March 2020GBT - Global Blood Therapeutics, Inc.7,500Exercise of derivative7,773$0.00
1st August 2020GBT - Global Blood Therapeutics, Inc.1,045Payment by withholding7,444$67.48$70,516.60$502,321.12
1st August 2020GBT - Global Blood Therapeutics, Inc.3,020Exercise of derivative8,489$0.00
31st July 2020GBT - Global Blood Therapeutics, Inc.290Grant/award etc.5,469$41.17$11,939.30$225,158.73
20th August 2020GBT - Global Blood Therapeutics, Inc.2,200Open or private sale5,244$63.77$140,294.00$334,409.88
1st September 2020GBT - Global Blood Therapeutics, Inc.1,551Payment by withholding7,443$60.45$93,757.95$449,929.35
1st September 2020GBT - Global Blood Therapeutics, Inc.3,750Exercise of derivative8,994$0.00